{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:11Z","timestamp":1761102251642,"version":"3.37.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["NCN 2012\/05\/B\/NZ7\/03102"],"award-info":[{"award-number":["NCN 2012\/05\/B\/NZ7\/03102"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["153-18696L","N\/ST\/MN\/16\/007\/1118"],"award-info":[{"award-number":["153-18696L","N\/ST\/MN\/16\/007\/1118"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.lfs.2017.06.019","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T05:17:05Z","timestamp":1497935825000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats"],"prefix":"10.1016","volume":"183","author":[{"given":"Agnieszka","family":"Polak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Kasacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"P\u0119dzi\u0144ska-Betiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Weresa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lfs.2017.06.019_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103479","article-title":"Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study","volume":"9","author":"Bj\u00f6rklund","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2010.11.002","article-title":"Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","article-title":"Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies","volume":"167","author":"Steffens","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"issue":"18","key":"10.1016\/j.lfs.2017.06.019_bb0025","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1074\/jbc.M211412200","article-title":"Characterization of a heart-specific fatty acid transport protein","volume":"278","author":"Gimeno","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.lfs.2017.06.019_bb0030","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2337\/diabetes.48.12.2255","article-title":"How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids?","volume":"48","author":"Hamilton","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2017.06.019_bb0035","first-page":"15","article-title":"Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence","volume":"22","author":"Bonen","year":"2007","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157340308783565429","article-title":"Protein-mediated fatty acid uptake in the heart","volume":"4","author":"Chabowski","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"issue":"15","key":"10.1016\/j.lfs.2017.06.019_bb0045","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1073\/pnas.95.15.8625","article-title":"A family of fatty acid transporters conserved from mycobacterium to man","volume":"95","author":"Hirsch","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.lfs.2017.06.019_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00210-006-0075-0","article-title":"Regulation of fatty acid transport: from transcriptional to posttranscriptional effects","volume":"373","author":"Chabowski","year":"2006","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2017.06.019_bb0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2337\/diabetes.52.7.1627","article-title":"Contraction-induced fatty acid translocase\/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling","volume":"52","author":"Luiken","year":"2003","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.lfs.2017.06.019_bb0060","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2337\/diabetes.51.10.3113","article-title":"Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT\/CD36","volume":"51","author":"Luiken","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cvr\/cvs164","article-title":"In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart","volume":"95","author":"Dodd","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/0975-7406.84435","article-title":"Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities","volume":"3","author":"Cunha","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"issue":"6","key":"10.1016\/j.lfs.2017.06.019_bb0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1012381914518","article-title":"Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion","volume":"131","author":"Krylatov","year":"2001","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2017.06.019_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","article-title":"Cannabinoid receptor signaling","volume":"168","author":"Howlett","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0085","doi-asserted-by":"crossref","first-page":"H533","DOI":"10.1152\/ajpheart.00107.2005","article-title":"Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase","volume":"289","author":"Pacher","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.lfs.2017.06.019_bb0090","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/HJH.0b013e3283591595","article-title":"Circulating anandamide and blood pressure in patients with obstructive sleep apnea","volume":"30","author":"Engeli","year":"2012","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.lfs.2017.06.019_bb0095","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/HJH.0b013e328329bbd7","article-title":"Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension","volume":"27","author":"Li","year":"2009","journal-title":"J. Hypertens."},{"issue":"14","key":"10.1016\/j.lfs.2017.06.019_bb0100","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"B\u00e1tkai","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.lfs.2017.06.019_bb0105","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.chembiol.2010.08.013","article-title":"Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects","volume":"17","author":"Godlewski","year":"2010","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pharep.2015.10.004","article-title":"Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats","volume":"68","author":"Toczek","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/1056-8719(92)90036-Z","article-title":"The pathogenesis of DOCA-salt hypertension","volume":"27","author":"Schenk","year":"1992","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"6 Pt 2","key":"10.1016\/j.lfs.2017.06.019_bb0120","first-page":"H1798","article-title":"Myocardial performance of STZ-diabetic DOCA-hypertensive rats","volume":"263","author":"Dai","year":"1992","journal-title":"Am. J. Phys."},{"issue":"4","key":"10.1016\/j.lfs.2017.06.019_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1179\/1351000212Y.0000000015","article-title":"The flavonoid morin restores blood pressure and lipid metabolism in DOCA-salt hypertensive rats","volume":"17","author":"Prahalathan","year":"2012","journal-title":"Redox Rep."},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/CBB:47:1:87","article-title":"Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase","volume":"47","author":"Loch","year":"2007","journal-title":"Cell Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.lfs.2017.06.019_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.phrs.2006.06.008","article-title":"The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues","volume":"54","author":"Clapper","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2017.06.019_bb0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fncel.2015.00098","article-title":"Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context","volume":"9","author":"Rivera","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"15","key":"10.1016\/j.lfs.2017.06.019_bb0145","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.febslet.2009.07.008","article-title":"Differential effects of chronic, in vivo, PPAR's stimulation on the myocardial subcellular redistribution of FAT\/CD36 and FABPpm","volume":"583","author":"Kalinowska","year":"2009","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/35.2.3098834","article-title":"Endogenous peroxidase activity in human cutaneous and adenoidal mast cells","volume":"35","author":"Escribano","year":"1987","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0160","doi-asserted-by":"crossref","first-page":"E491","DOI":"10.1152\/ajpendo.00419.2001","article-title":"Insulin induces the translocation of the fatty acid transporter FAT\/CD36 to the plasma membrane","volume":"282","author":"Luiken","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/abio.2001.5127","article-title":"Differential centrifugation separates cardiac sarcolemmal and endosomal membranes from Langendorff-perfused rat hearts","volume":"293","author":"Fuller","year":"2001","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1159\/000430238","article-title":"Myocardial lipid profiling during time course of high fat diet and its relationship to the expression of fatty acid transporters","volume":"37","author":"Harasim","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0175","first-page":"165","article-title":"Receptory kannabinoid\u00f3w i ich endogenne i egzogenne ligandy","volume":"13","author":"Bogdan","year":"2000","journal-title":"Alkoholizm i Narkomania"},{"issue":"4","key":"10.1016\/j.lfs.2017.06.019_bb0180","first-page":"e25","article-title":"Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lfs.2017.06.019_bb0185","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/ndt\/gfm321","article-title":"High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?","volume":"22","author":"Burnier","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0190","doi-asserted-by":"crossref","first-page":"E705","DOI":"10.1152\/ajpendo.90338.2008","article-title":"Cardiac metabolic compensation to hypertension requires lipoprotein lipase","volume":"295","author":"Yamashita","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.lfs.2017.06.019_bb0195","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1006\/jmcc.1994.1155","article-title":"Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat","volume":"26","author":"Christe","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"26","key":"10.1016\/j.lfs.2017.06.019_bb0200","doi-asserted-by":"crossref","first-page":"23661","DOI":"10.1074\/jbc.M100942200","article-title":"Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy","volume":"276","author":"Hajri","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2017.06.019_bb0205","first-page":"109","article-title":"Heart metabolic modifications induced by nifedipine treatment in normo- and hypertensive Wistar rats","volume":"30","author":"Coprean","year":"1993","journal-title":"Rom. J. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2017.06.019_bb0210","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1194\/jlr.M800237-JLR200","article-title":"FAT\/CD36 expression is not ablated in spontaneously hypertensive rats","volume":"50","author":"Bonen","year":"2009","journal-title":"J. Lipid Res."},{"issue":"5400","key":"10.1016\/j.lfs.2017.06.019_bb0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.lfs.2017.06.019_bb0220","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0005-2760(94)00082-4","article-title":"Regulation of fatty acid oxidation in the mammalian heart in health and disease","volume":"1213","author":"Lopaschuk","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.lfs.2017.06.019_bb0230","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.lfs.2017.06.019_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055963","article-title":"Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia","volume":"8","author":"Geurts","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.beem.2008.10.002","article-title":"The role of the endocannabinoid system in lipogenesis and fatty acid metabolism","volume":"23","author":"Vettor","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.lfs.2017.06.019_bb0245","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","article-title":"Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification","volume":"50","author":"Ouwens","year":"2007","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lfs.2017.06.019_bb0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517303053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517303053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T05:37:44Z","timestamp":1656049064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517303053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":50,"alternative-id":["S0024320517303053"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.06.019","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}